Source:http://linkedlifedata.com/resource/pubmed/id/11572871
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
47
|
pubmed:dateCreated |
2001-11-19
|
pubmed:abstractText |
Morphine and the endogenous opioid peptide beta-endorphin exert neuromodulatory as well as immunomodulatory effects, which are transduced by mu-opioid receptors. In this report we show that stimulation with interleukin-4 induces mu-opioid receptor transcripts in human primary blood cells (T cells and polymorphonuclear leukocytes), immune cell lines (Raji, U-937, and HMEC-1), and dendritic cells. In nonstimulated immune cells this gene is silent. In addition, mu receptor transcription is up-regulated by interleukin-4 in cultures of primary rat neurons. Transient transfection experiments in Raji and SH SY5Y neuronal cells with human and rat reporter gene constructs linked the interleukin-4 effect directly to cis-active mu receptor promoter elements located at nucleotide -997 on the human gene and nucleotide -727 on the rat gene. The interleukin-4 response elements function orientation independently. They bind STAT6 transcription factors as shown by electrophoretic mobility shift assays. In the human gene, a single nucleotide polymorphism within the interleukin-4 response element reduces the trans-activating potential of this element by 50%, which may affect the phenotype of persons carrying this variation. These findings provide a molecular basis for understanding bidirectional interactions between the opioid system and the immune system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu,
http://linkedlifedata.com/resource/pubmed/chemical/STAT6 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/STAT6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43901-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11572871-Alleles,
pubmed-meshheading:11572871-Base Sequence,
pubmed-meshheading:11572871-Binding Sites,
pubmed-meshheading:11572871-Cell Line,
pubmed-meshheading:11572871-Cerebral Cortex,
pubmed-meshheading:11572871-DNA Primers,
pubmed-meshheading:11572871-Gene Expression Regulation,
pubmed-meshheading:11572871-Genetic Variation,
pubmed-meshheading:11572871-Humans,
pubmed-meshheading:11572871-Interleukin-4,
pubmed-meshheading:11572871-Neurons,
pubmed-meshheading:11572871-Polymorphism, Single Nucleotide,
pubmed-meshheading:11572871-Promoter Regions, Genetic,
pubmed-meshheading:11572871-Receptors, Opioid, mu,
pubmed-meshheading:11572871-STAT6 Transcription Factor,
pubmed-meshheading:11572871-Trans-Activators,
pubmed-meshheading:11572871-Transcription, Genetic
|
pubmed:year |
2001
|
pubmed:articleTitle |
Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site.
|
pubmed:affiliation |
Department of Pharmacology, University of Magdeburg, 44 Leipziger Strasse, 39120 Magdeburg, Germany. juergen.kraus@medizin.uni-magdeburg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|